Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Passage Bio Inc (NQ: PASG )

0.6500 -0.0080 (-1.22%)
Streaming Delayed Price Updated: 12:43 PM EDT, Oct 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 19,854
Open 0.6494
Bid (Size) 0.6500 (4)
Ask (Size) 0.6595 (2)
Prev. Close 0.6580
Today's Range 0.6494 - 0.6700
52wk Range 0.6511 - 1.920
Shares Outstanding 54,811,305
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference
From Passage Bio
Via GlobeNewswire
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
From Passage Bio
Via GlobeNewswire

Performance

YTD
-59.88%
-59.88%
1 Month
-16.02%
-16.02%
3 Month
-28.27%
-28.27%
6 Month
-45.38%
-45.38%
1 Year
-55.48%
-55.48%

More News

Read More
Passage Bio Announces Promising Interim Clinical Data from First Eight Patients with GM1 Gangliosidosis in Imagine-1 Study
From Passage Bio
Via GlobeNewswire
Recap: Passage Bio Q1 Earnings
Via Benzinga
Passage Bio's Earnings: A Preview
Via Benzinga
Expert Ratings for Passage Bio
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Passage Bio to Participate in Upcoming Investor Conferences
From Passage Bio
Via GlobeNewswire
Passage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of Directors
From Passage Bio
Via GlobeNewswire
Passage Bio And 2 Other Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare Conference
From Passage Bio
Via GlobeNewswire
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
From Passage Bio
Via GlobeNewswire
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Passage Bio
Via GlobeNewswire
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
From Passage Bio
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days
From Passage Bio
Via GlobeNewswire
Passage Bio Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Recent Business Highlights
From Passage Bio
Via GlobeNewswire
Passage Bio to Present at Cowen 43rd Annual Health Care Conference
From Passage Bio
Via GlobeNewswire
Passage Bio to Report Fourth Quarter and Full-Year 2022 Financial Results on March 6, 2023
From Passage Bio
Via GlobeNewswire
Passage Bio Presents Additional Interim Data from Imagine-1 Study for GM1 Gangliosidosis at 19th Annual WORLDSymposium™ 2023
From Passage Bio
Via GlobeNewswire
Passage Bio to Present Updated Interim Data from Imagine-1 Study for GM1 Gangliosidosis at 19th Annual WORLDSymposium™ 2023
From Passage Bio
Via GlobeNewswire
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Passage Bio
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.